Eli Lilly’s and Novo Nordisk’s Weight-Loss Drugs—and Their Stocks—Could Take Off. | Barron’s

A new class of drugs developed by Eli Lilly and Novo Nordisk have shown striking results in studies, letting many people safely lose 20% of their weight. If insurers step up to back them, the drugs—and the stocks—could take off.

This content was originally published here.

Can't Get enough Freebie, Subscribe

We will send you the latest digital Marketing technology and methods that should help you grow your business.

Custom Keto Diet

Venus Factor

All day slimming tea

 

ikaria Juice

 

Apple Cider Vinegar Ebook Membership